Yadav Siddharth, Farinha Rui, Aravind T K, Singh Harshdeep, Raheja Ankit, Vasudeva Pawan, Kumar Anup
Department of Urology, Vardhaman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.
Department of Urology, Lusíadas Hospital, Lisbon, Portugal.
Indian J Urol. 2025 Jul-Sep;41(3):166-175. doi: 10.4103/iju.iju_3_25. Epub 2025 Jul 1.
This systematic review and meta-analysis were performed to generate evidence on the complication rates between robot-assisted radical cystectomy and intracorporeal ileal conduit (RARC ICIC) and RARC and intracorporeal orthotopic neobladder (RARC ICONB).
A systematic search of the PubMed, Scopus, and Web of Science databases was performed, and all the articles from inception up to June 30, 2024, were screened. Studies reporting on perioperative complications as per the Clavien-Dindo classification and comparing RARC ICIC with RARC ICONB were included. This systematic review was performed as per the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines.
A total of 9 studies evaluating 999 patients were included in the final analysis, and all were retrospective analyses of prospectively maintained databases. The 30-day and 90-day complication rates, including the Clavien-Dindo I-II and III-V and the overall complication rate, were similar between RARC ICIC and RARC ICONB. RARC ICONB had a longer operative time (weighted mean difference - 69.62 min) and higher blood loss (weighted mean difference - 50.53 ml). Patients with stage pT4 and N1 were more in the RARC ICIC group as was the rate of positive surgical margin, which suggests an inherent selection bias while offering the procedure.
This systematic review, which included only retrospective small-sized series, found that the 30-day and 90-day complication rates between RARC ICIC and RARC ICONB are similar; however, these results are marred by apparent selection bias while offering the procedure. Thus, larger, better-quality prospective randomized studies are required to provide high-quality evidence.
本系统评价和荟萃分析旨在获取有关机器人辅助根治性膀胱切除术与体内回肠膀胱术(RARC ICIC)以及RARC与体内原位新膀胱术(RARC ICONB)之间并发症发生率的证据。
对PubMed、Scopus和Web of Science数据库进行系统检索,并筛选了从建库至2024年6月30日的所有文章。纳入了根据Clavien-Dindo分类报告围手术期并发症并比较RARC ICIC与RARC ICONB的研究。本系统评价按照系统评价和荟萃分析的首选报告项目指南进行。
最终分析纳入了共9项评估999例患者的研究,所有研究均为对前瞻性维护数据库的回顾性分析。RARC ICIC与RARC ICONB之间的30天和90天并发症发生率,包括Clavien-Dindo I-II级和III-V级以及总体并发症发生率相似。RARC ICONB的手术时间更长(加权平均差 - 69.62分钟)且失血量更多(加权平均差 - 50.53毫升)。pT4期和N1期患者在RARC ICIC组中更多,手术切缘阳性率也是如此,这表明在提供该手术时存在内在的选择偏倚。
本系统评价仅纳入了回顾性小样本系列研究,发现RARC ICIC与RARC ICONB之间的30天和90天并发症发生率相似;然而,在提供该手术时这些结果存在明显的选择偏倚。因此,需要开展更大规模、质量更高的前瞻性随机研究以提供高质量证据。